One study measured serum IL‐17 levels by ELISA and found higher levels in the AD group (10.47 ± 3.39 pg/ml) compared with the control group (9.63 ± 3.36 pg/ml), but this difference was not statistically significant.25 This evidence concerns the gene IL17A and Alzheimer disease.